PBYI compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

PBYIPuma Biotechnology, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

PBYIPuma Biotechnology, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PBYI

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±45.0%▲+9.73%×0.22

May 8 '26±42.0%▲+3.17%×0.08

Q1 FY26±21.7%▼−25.00%×1.15

Q3 FY25±18.4%▲+22.24%×1.21

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedPBYI realized, solidLLY realized, hatchedOne scale, both sides: full bar = 46%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

PBYIPuma Biotechnology, Inc.

10.42▲+2.33%· post 10.21· delayed

Mkt cap$525.5MRevenue$57MQ2 FY26Revenue$228MFY25

LLYELI Lilly & Co

1,407.25▼−0.27%· post 1,407.54· delayed

After hoursNov 3 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

After hoursNov 3 '26delayed

PBYIPuma Biotechnology, Inc.

LLYELI Lilly & Co

10.42▲+2.33%post 10.21delayed

Price

1,407.25▼−0.27%post 1,407.54delayed

$525.5M

Mkt cap

$1.3T

Q2 FY26$57M

Revenue

$24.4BQ3 FY26

FY25$228M

Revenue

$65.2BFY25

PBYI10.42▲+2.33%vsLLY1,407.25▼−0.27%After hoursNov 3 '26delayed